| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 23,952 | 43,032 | 71,522 | | Selling General and Administrative | 10,560 | 15,941 | 16,288 | | Non Recurring | 196 | 1,356 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (34,708) | (60,329) | (87,810) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,945 | 5,183 | 8,243 | | Earnings Before Interest And Taxes | (31,763) | (55,146) | (79,567) | | Interest Expense |
-
| 69 | 57 | | Income Before Tax | (31,763) | (55,215) | (79,624) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,763) | (55,215) | (79,624) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (31,763) | (55,215) | (79,624) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,763) | ($55,215) | ($79,624) |
|
0.29% Nasdaq 
0.01 (1.37%) 
Income Statement
